Alcedis GmbH stands for long years of CRO experience and profound expertise in the conduct of clinical trials. One focal point distinguishing Alcedis is our innovative software systems constitute a centrepiece of the Alcedis trademark.

Our module-based service concept adjusts itself flexibly to your project structure. Likewise individually adapted are our data entry and software systems.

With our network of qualified partners, we conduct national or international phase I to IV multi-center studies, non-interventional studies and registers for medicinal products and medical devices.

 

 

 

 





03.08.2020 / On the forefront in the fight against COVID-19
Alcedis Gmbh, a clinical research organisation at the Giessen Technology and Innovation Centre, is currently participating in three clinical studies. The aim is to find new approaches to prevent and treat the COVID-19 infection. The article has been published by Healthcare Mittelhessen (https://healthcare-mittelhessen.eu/alcedis-covid19?lang=en)     The current global ...
29.07.2020 / Artificial intelligence in clinical research
  Artificial intelligence (AI), machine learning (ML), artificial neural networks (ANN) or deep learning (DL) are just some of the buzzwords one seems to catch almost everywhere for a while now. This totally makes sense since highly efficient and precise automatization and / or decision making is appealing for lots and lots of fields and applications, hence also for clinical researc...
17.07.2020 / Gießener Anzeiger: Big Data contra Coronavirus at pharmaceutical service provider Alcedis
The Gießen-based pharmaceutical service provider Alcedis is forging three irons in the fight against the corona virus. But the word "race" is not a word they like to hear in connection with the development of a new drug. → Here is the link to the full article by Ingo Berghöfer, Gießener Anzeiger.
15.06.2020 / An era ends. New leadership team at Alcedis.
After more than 25 years, the founders of Alcedis, Dr. Elke Heidrich-Lorsbach and Michael Lorsbach, will retire on 31 Dec 2020 from the operational business. This announcement was delivered during an internal staff meeting on 28 May 2020.   This was decided some time ago, in order for a well prepared and timely organisation of the successors and the repositioning of the management te...
15.04.2020 / How Big Data accelerates drug development
On their path towards approval, drugs go through a research process that takes years. In many cases, these medicines come too late for some patients who do not respond to existing therapies. The contract research organization Alcedis, headquarted in Giessen, knows how to accelerate the drug development process with the help of digital software – for the benefit of patients. Read the full st...

 

Facts

+20
Years of Experience
+143
Employees
+420.000
Patients
+400
Projects
49
Countries
5.213.542
Lines software code

Partner and References

Our clients and partner are at home all over this globe. Check out a choice of references.